risperdal

07/01/2014

Whistleblower Lawsuit Against Omnicare Nets $124 Million for Federal Government

Whistleblower Award

The Federal government has accepted a $124 million settlement from Omnicare to resolve several claims initiated by company employees who reported illegal kickbacks and other improprieties to regulators.  Omnicare is the largest provider of pharmaceuticals and pharmacy services to nursing homes in the United States. The whistleblower lawsuits, brought under the federal False Claims Act, challenged Omnicare's practice of offering below-cost contracts to supply pharmaceuticals and pharmacy services to skilled nursing facilities to secure provider contracts with these facilities.  According to... Read More
05/27/2014

Risperdal Lawsuits Time Barred, Argues Johnson & Johnson

Risperdal Lawsuit Bars Claims for Punitive Damages

Janssen Pharmaceuticals, a division of Johnson & Johnson  that manufactured and marketed the antipsychotic drug Risperdal to adolescent males, asked a Pennsylvania court in a Motion for Summary Judgment dated May 19, 2014, to hold that hundreds of personal injury claims connected to Risperdal administration should be time barred by the applicable statute of limitations.  In its Motion, Janssen has argued that plaintiffs have filed injury claims years, and in some cases, decades after developing a condition called gynecomastia, and... Read More
04/16/2014

Whistleblower Lawsuits On The Rise

Whistleblower Award

Whistleblower claims, or "qui tam" lawsuits, brought under the federal False Claims Act, increased to 753 in 2013, an increase of almost 20% over the previous year.*  These claims resulted in aggregate net recoveries to the federal government of $3.8 billion last year.  For the past four years, whistleblower lawsuits have produced recoveries to the federal government exceeding an aggregate amount of $3 billion. What is driving the rise in whistleblower lawsuits under the False Claims Act?  False claims involving healthcare... Read More
03/11/2014

Risperdal Lawsuits Stress Demonstrated Link to Enlarged Breast Tissue in Males

Risperdal Lawyers

Audet & Partners, LLP is investigating claims for serious personal injuries, including breast enlargement in males, tied to administration of the antipsychotic drug Risperdal.  Commonly prescribed to treat schizophrenia and bipolar disorder, and occasionally used off-label to address ADHD, Risperdal has been shown in several studies over the past fifteen years to be strongly linked to elevated levels of prolactin in males, a hormonal precursor to breast development and lactation in women. This condition, referred to as Risperdal Gynecomastia, is irreversible.... Read More
10/28/2009

Antipsychotic Drugs Add To Kids’ Weight – NPR Health Blog : NPR

Antipsychotic Drugs Add To Kids' Weight - NPR Health Blog : NPR: "Antipsychotic drugs used in kids can carry a steep health cost. Many children gain an unhealthy amount of weight after just a few months on the medicines.Research just published in JAMA found the drugs led to weight gains ranging from about 10 to 19 pounds, depending on the medicine, in about 11 weeks. The analysis looked at popular brand-name drugs Abilify, Risperdal, Seroquel and Zyprexa."... Read More